Silvec Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Silvec Biologics's estimated annual revenue is currently $2.5M per year.
- Silvec Biologics's estimated revenue per employee is $155,000
Employee Data
- Silvec Biologics has 16 Employees.
- Silvec Biologics grew their employee count by 7% last year.
Silvec Biologics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and President | Reveal Email/Phone |
2 | Horticulture and Propagation Manager | Reveal Email/Phone |
3 | Biological Lab Technician and Training Coordinator | Reveal Email/Phone |
Silvec Biologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Silvec Biologics?
Silvec has discovered a new type of RNA that can be used to deliver beneficial traits to trees, vines, and bushes, without impacting their genomes. Its proprietary products can be applied via a single graft taking minutes to perform in seedlings or mature trees that induce them to produce their own anti-pathogenic or trait enhancing agents for the remainder of their lives. It does not damage them in any way, is not heritable, and does not spread from tree-to-tree. In January 2020, we successfully inoculated the first plant in history against a deadly disease. We believe this represents a comparable breakthrough for trees as the invention of vaccines and antibiotics have had for humans.
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 16 | -11% | $64M |
#2 | $2.5M | 16 | 0% | N/A |
#3 | $1M | 16 | 14% | N/A |
#4 | $2.5M | 16 | 33% | N/A |
#5 | $1.5M | 17 | 0% | N/A |